INMD – Blue& White for long
An Israeli company - healthcare
InMode Established in 2008 profitable for several years now. A new ipo - 3 months ago at a price of 14$ and since then has jumped tens of percent.
Total revenue for the second quarter of 2019 was $ 38.8 million, up 55% from the second quarter of 2018. Mainly as a result of higher U.S. revenue.
Gross profitability in the second quarter of 2019 stood at 87%, compared with 84% in the second quarter of 2018.
Operating profitability in the second quarter of 2019 was 41%, compared to the operating margin of 31% in the second quarter of 2018. An increase mainly attributable to the increase in gross profit.
Reported a net profit of $ 15.8 million in the second quarter of 2019 compared to a net profit of $ 7.6 million in the second quarter of 2018.
The company receives positive feedback from doctors and customers who consume their products and service, demonstrating reputation and quality alongside safety. Also, InMode stock is highly rated according to Business Investor Daily standards.
Support level was created at 29.5.
Entry over 32 can be scheduled after a candle is approved, or you can wait for a correction and schedule a resale for further increases.
All of the above, of course, at your own discretion, your trading rules and your preferred trading strategies.
This is not a recommendation to buy or sell.
Good luck..
InMode Established in 2008 profitable for several years now. A new ipo - 3 months ago at a price of 14$ and since then has jumped tens of percent.
Total revenue for the second quarter of 2019 was $ 38.8 million, up 55% from the second quarter of 2018. Mainly as a result of higher U.S. revenue.
Gross profitability in the second quarter of 2019 stood at 87%, compared with 84% in the second quarter of 2018.
Operating profitability in the second quarter of 2019 was 41%, compared to the operating margin of 31% in the second quarter of 2018. An increase mainly attributable to the increase in gross profit.
Reported a net profit of $ 15.8 million in the second quarter of 2019 compared to a net profit of $ 7.6 million in the second quarter of 2018.
The company receives positive feedback from doctors and customers who consume their products and service, demonstrating reputation and quality alongside safety. Also, InMode stock is highly rated according to Business Investor Daily standards.
Support level was created at 29.5.
Entry over 32 can be scheduled after a candle is approved, or you can wait for a correction and schedule a resale for further increases.
All of the above, of course, at your own discretion, your trading rules and your preferred trading strategies.
This is not a recommendation to buy or sell.
Good luck..
,The quieter you become
the more you can hear
(Ram Dass)
the more you can hear
(Ram Dass)
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.